American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics, 2004; 114:297–316.
2.
MaiselsMJ.Managing the jaundiced newborn: A persistent challenge. CMAJ, 2015; 187:335–343.
3.
PreerGL, PhilippBL. Understanding and managing breast milk jaundice. Arch Dis Child Fetal Neonatal Ed, 2011; 96:F461–F466.
4.
OlusanyaBO, OsibanjoFB, SlusherTM. Risk factors for severe neonatal hyperbilirubinemia in low and middle-income countries: A systematic review and meta-analysis. PLoS One, 2015; 10:e0117229.
BhutaniVK, StarkAR, LazzeroniLC, et al.Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy. J Pediatr, 2013; 162:477–482 e471.
7.
KerenR, LuanX, FriedmanS, et al.A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants. Pediatrics, 2008; 121:e170–e179.
8.
FouzasS, MantagouL, SkylogianniE, et al.Transcutaneous bilirubin levels for the first 120 postnatal hours in healthy neonates. Pediatrics, 2010; 125:e52–e57.
9.
De LucaD, RomagnoliC, TiberiE, et al.Skin bilirubin nomogram for the first 96 h of life in a European normal healthy newborn population, obtained with multiwavelength transcutaneous bilirubinometry. Acta Paediatr, 2008; 97:146–150.
10.
BhutaniVK, VilmsRJ, Hamerman-JohnsonL. Universal bilirubin screening for severe neonatal hyperbilirubinemia. J Perinatol, 2010; 30Suppl:S6–S15.
11.
MaiselsMJ.What's in a name? Physiologic and pathologic jaundice: The conundrum of defining normal bilirubin levels in the newborn. Pediatrics, 2006; 118:805–807.
12.
BertiniG, DaniC, TronchinM, et al.Is breastfeeding really favoring early neonatal jaundice?. Pediatrics, 2001; 107:E41.
13.
DahmsBB, KraussAN, GartnerLM, et al.Breast feeding and serum bilirubin values during the first 4 days of life. J Pediatr, 1973; 83:1049–1054.
14.
JangaardKA, FellDB, DoddsL, et al.Outcomes in a population of healthy term and near-term infants with serum bilirubin levels of >or = 325 micromol/L (> or = 19 mg/dL) who were born in Nova Scotia, Canada, between 1994 and 2000. Pediatrics, 2008; 122:119–124.
15.
KaplanM, HerschelM, HammermanC, et al.Neonatal hyperbilirubinemia in African American males: The importance of glucose-6-phosphate dehydrogenase deficiency. J Pediatr, 2006; 149:83–88.
16.
KuzniewiczMW, EscobarGJ, WiS, et al.Risk factors for severe hyperbilirubinemia among infants with borderline bilirubin levels: A nested case-control study. J Pediatr, 2008; 153:234–240.
17.
ChenCF, HsuMC, ShenCH, et al.Influence of breast-feeding on weight loss, jaundice, and waste elimination in neonates. Pediatr Neonatol, 2011; 52:85–92.
18.
YangH, WangQ, ZhengL, et al.Multiple genetic modifiers of bilirubin metabolism involvement in significant neonatal hyperbilirubinemia in patients of Chinese descent. PLoS One, 2015; 10:e0132034.
19.
NewmanTB, XiongB, GonzalesVM, et al.Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med, 2000; 154:1140–1147.
20.
HuangMS, LinMC, ChenHH, et al.Risk factor analysis for late-onset neonatal hyperbilirubinemia in Taiwanese infants. Pediatr Neonatol, 2009; 50:261–265.
21.
MaiselsMJ, BhutaniVK, BogenD, et al.Hyperbilirubinemia in the newborn infant > or = 35 weeks' gestation: An update with clarifications. Pediatrics, 2009; 124:1193–1198.
22.
ItohS, KondoM, KusakaT, et al.Differences in transcutaneous bilirubin readings in Japanese term infants according to feeding method. Pediatr Int, 2001; 43:12–15.
23.
De CarvalhoM, RobertsonS, KlausM. Fecal bilirubin excretion and serum bilirubin concentrations in breast-fed and bottle-fed infants. J Pediatr, 1985; 107:786–790.
24.
BuiterHD, DijkstraSS, Oude ElferinkRF, et al.Neonatal jaundice and stool production in breast- or formula-fed term infants. Eur J Pediatr, 2008; 167:501–507.
25.
GartnerLM.Breastfeeding and jaundice. J Perinatol, 2001; 21Suppl 1:S25–S29.
26.
FlahermanVJ, GayB, ScottC, et al.Randomised trial comparing hand expression with breast pumping for mothers of term newborns feeding poorly. Arch Dis Child Fetal Neonatal Ed, 2012; 97:F18–F23.
27.
ChapmanDJ, YoungS, FerrisAM, et al.Impact of breast pumping on lactogenesis stage II after cesarean delivery: A randomized clinical trial. Pediatrics, 2001; 107:E94.
28.
EvansKC, EvansRG, RoyalR, et al.Effect of caesarean section on breast milk transfer to the normal term newborn over the first week of life. Arch Dis Child Fetal Neonatal Ed, 2003; 88:F380–F382.
29.
SantoroWJr, MartinezFE, RiccoRG, et al.Colostrum ingested during the first day of life by exclusively breastfed healthy newborn infants. J Pediatr, 2010; 156:29–32.
30.
AaltonenT, Alvarez GonzalezB, AmerioS, et al.Measurement of b hadron lifetimes in exclusive decays containing a J/psi in pp collisions at radicals = 1.96 TeV. Phys Rev Lett, 2011; 106:121804.
31.
SaintL, SmithM, HartmannPE. The yield and nutrient content of colostrum and milk of women from giving birth to 1 month post-partum. Br J Nutr, 1984; 52:87–95.
32.
WhitmerDI, GollanJL. Mechanisms and significance of fasting and dietary hyperbilirubinemia. Semin Liver Dis, 1983; 3:42–51.
33.
WhiteGLJr, NelsonJA, PedersenDM, et al.Fasting and gender (and altitude?) influence reference intervals for serum bilirubin in healthy adults. Clin Chem, 1981; 27:1140–1142.
34.
BloomerJR, BarrettPV, RodkeyFL, et al.Studies on the mechanism of fasting hyperbilirubinemia. Gastroenterology, 1971; 61:479–487.
35.
FeveryJ.Fasting hyperbilirubinemia: Unraveling the mechanism involved. Gastroenterology, 1997; 113:1798–1800.
36.
PangWW, HartmannPE. Initiation of human lactation: Secretory differentiation and secretory activation. J Mammary Gland Biol Neoplasia, 2007; 12:211–221.
37.
De CarvalhoM, KlausMH, MerkatzRB. Frequency of breast-feeding and serum bilirubin concentration. Am J Dis Child, 1982; 136:737–738.
38.
YamauchiY, YamanouchiI. Breast-feeding frequency during the first 24 hours after birth in full-term neonates. Pediatrics, 1990; 86:171–175.
39.
WuPY, HodgmanJE, KirkpatrickBV, et al.Metabolic aspects of phototherapy. Pediatrics, 1985; 75(2 Pt 2):427–433.
40.
Davila-GrijalvaH, TroyaAH, KringE, et al.How much do formula-fed infants take in the first 2 days?. Clin Pediatr, 2016;pii: 0009922816637647.
41.
SatoH, UchidaT, ToyotaK, et al.Association of neonatal hyperbilirubinemia in breast-fed infants with UGT1A1 or SLCOs polymorphisms. J Hum Genet, 2015; 60:35–40.
42.
SatoH, UchidaT, ToyotaK, et al.Association of breast-fed neonatal hyperbilirubinemia with UGT1A1 polymorphisms: 211G>A (G71R) mutation becomes a risk factor under inadequate feeding. J Hum Genet, 2013; 58:7–10.
43.
MaiselsMJ, CluneS, ColemanK, et al.The natural history of jaundice in predominantly breastfed infants. Pediatrics, 2014; 134:e340–e345.
44.
KivlahanC, JamesEJ. The natural history of neonatal jaundice. Pediatrics, 1984; 74:364–370.
45.
American Academy of Pediatrics. Breastfeeding and the use of human milk. Pediatrics, 2012; 129:e827–e841.
46.
VerkadeHJ.A novel hypothesis on the pathophysiology of neonatal jaundice. J Pediatr, 2002; 141:594–595.
47.
ApaydinK, ErmisB, ArasliM, et al.Cytokines in human milk and late-onset breast milk jaundice. Pediatr Int, 2012; 54:801–805.
48.
UrasN, TonbulA, KaradagA, et al.Prolonged jaundice in newborns is associated with low antioxidant capacity in breast milk. Scand J Clin Lab Invest, 2010; 70:433–437.
49.
BozkayaOG, KumralA, YesilirmakDC, et al.Prolonged unconjugated hyperbilirubinaemia associated with the haem oxygenase-1 gene promoter polymorphism. Acta Paediatr, 2010; 99:679–683.
50.
ZajaO, TiljakMK, StefanovicM, et al.Correlation of UGT1A1 TATA-box polymorphism and jaundice in breastfed newborns-early presentation of Gilbert's syndrome. J Matern Fetal Neonatal Med, 2014; 27:844–850.
51.
ChouHC, ChenMH, YangHI, et al.211 G to a variation of UDP-glucuronosyl transferase 1A1 gene and neonatal breastfeeding jaundice. Pediatr Res, 2011; 69:170–174.
52.
KumralA, OzkanH, DumanN, et al.Breast milk jaundice correlates with high levels of epidermal growth factor. Pediatr Res, 2009; 66:218–221.
53.
ManganaroR, MarsegliaL, MamiC, et al.Serum alpha-fetoprotein (AFP) levels in breastfed infants with prolonged indirect hyperbilirubinemia. Early Hum Dev, 2008; 84:487–490.
54.
NagaoY, OhsawaM, KobayashiT. Correlation between unconjugated bilirubin and total cholesterol in the sera of 1-month-old infants. J Paediatr Child Health, 2010; 46:709–713.
55.
TuzunF, KumralA, DumanN, et al.Breast milk jaundice: Effect of bacteria present in breast milk and infant feces. J Pediatr Gastroenterol Nutr, 2013; 56:328–332.
56.
WatchkoJF, LinZ. Genetics of neonatal jaundice. In: Care of the Jaundiced Neonate, StevensonDK, MaiselsMJ, WatchkoJF, eds. New York, NY: McGraw Hill, 2012, pp. 1–27.
57.
ChangRJ, ChouHC, ChangYH, et al.Weight loss percentage prediction of subsequent neonatal hyperbilirubinemia in exclusively breastfed neonates. Pediatr Neonatol, 2012; 53:41–44.
58.
ChenYJ, ChenWC, ChenCM. Risk factors for hyperbilirubinemia in breastfed term neonates. Eur J Pediatr, 2012; 171:167–171.
59.
HuangA, TaiBC, WongLY, et al.Differential risk for early breastfeeding jaundice in a multi-ethnic Asian cohort. Ann Acad Med Singapore, 2009; 38:217–224.
60.
HuangHC, YangHI, ChangYH, et al.Model to predict hyperbilirubinemia in healthy term and near-term newborns with exclusive breast feeding. Pediatr Neonatol, 2012; 53:354–358.
61.
SalasAA, SalazarJ, BurgoaCV, et al.Significant weight loss in breastfed term infants readmitted for hyperbilirubinemia. BMC Pediatr, 2009; 9:82.
62.
YangWC, ZhaoLL, LiYC, et al.Bodyweight loss in predicting neonatal hyperbilirubinemia 72 hours after birth in term newborn infants. BMC Pediatr, 2013; 13:145.
63.
EbbesenF, BjerreJV, VandborgPK. Relation between serum bilirubin levels >/ = 450 mumol/L and bilirubin encephalopathy; a Danish population-based study. Acta Paediatr, 2012; 101:384–389.
64.
KuzniewiczMW, WickremasingheAC, WuYW, et al.Incidence, etiology, and outcomes of hazardous hyperbilirubinemia in newborns. Pediatrics, 2014; 134:504–509.
65.
NewmanTB, KuzniewiczMW. Follow-up of extreme neonatal hyperbilirubinaemia: More reassuring results from Denmark. Dev Med Child Neurol, 2015; 57:314–315.
66.
BhutaniVK, ZipurskyA, BlencoweH, et al.Neonatal hyperbilirubinemia and Rhesus disease of the newborn: Incidence and impairment estimates for 2010 at regional and global levels. Pediatr Res, 2013; 74Suppl 1:86–100.
67.
BhutaniVK, JohnsonLH, Jeffrey MaiselsM, et al.Kernicterus: Epidemiological strategies for its prevention through systems-based approaches. J Perinatol, 2004; 24:650–662.
68.
MaiselsMJ, NewmanTB. Kernicterus in otherwise healthy, breast-fed term newborns. Pediatrics, 1995; 96(4 Pt 1):730–733.
69.
RighardL, AladeMO. Effect of delivery room routines on success of first breast-feed. Lancet, 1990; 336:1105–1107.
70.
Mikiel-KostyraK, MazurJ, BoltruszkoI. Effect of early skin-to-skin contact after delivery on duration of breastfeeding: A prospective cohort study. Acta Paediatr, 2002; 91:1301–1306.
71.
BramsonL, LeeJW, MooreE, et al.Effect of early skin-to-skin mother–infant contact during the first 3 hours following birth on exclusive breastfeeding during the maternity hospital stay. J Hum Lact, 2010; 26:130–137.
72.
MooreER, BergmanN, AndersonGC, et al.Early skin-to-skin contact for mothers and their healthy newborn infants. Cochrane Database Syst Rev, 2016. DOI:10.1002/14651858.CD003519.pub4
73.
ShekellePG, WoolfSH, EcclesM, et al.Developing guidelines. BMJ, 1999; 318:593–596.
74.
BoskabadiH, ZakerihamidiM.The correlation between frequency and duration of breastfeeding and the severity of neonatal hyperbilirubinemia. J Matern Fetal Neonatal Med, 2017. DOI:10.1080/14767058.2017.1287897
75.
DeweyKG, Nommsen-RiversLA, HeinigMJ, et al.Risk factors for suboptimal infant breastfeeding behavior, delayed onset of lactation, and excess neonatal weight loss. Pediatrics, 2003; 112(3 Pt 1):607–619.
76.
BoiesEG, VaucherYE, The Academy of Breastfeeding Medicine. ABM Clinical Protocol #10: Breastfeeding the late preterm (34–36 6/7 weeks of gestation) and early term infants (37–38 6/7 weeks of gestation), second revision 2016. Breastfeed Med, 2016; 11:494–500.
77.
KellamsA, HarrelC, OmageS, et al.ABM clinical protocol #3: Supplementary feedings in the healthy term breastfed neonate. Breastfeed Med, 2017; 12:188–198.
78.
National Institute for Health and Care Excellence (NICE). Jaundice in Newborn Babies Under 28 Days. NICE, London, 2016.
79.
BratlidD, NakstadB, HansenTW. National guidelines for treatment of jaundice in the newborn. Acta Paediatr, 2011; 100:499–505.
80.
Guidelines for detection, management and prevention of hyperbilirubinemia in term and late preterm newborn infants (35 or more weeks' gestation)—Summary. Paediatr Child Health, 2007; 12:401–418.
81.
FlahermanVJ, HicksKG, CabanaMD, et al.Maternal experience of interactions with providers among mothers with milk supply concern. Clin Pediatr, 2012; 51:778–784.
82.
KairLR, FlahermanVJ, NewbyKA, et al.The experience of breastfeeding the late preterm infant: A qualitative study. Breastfeed Med, 2015; 10:102–106.
HillPD.The enigma of insufficient milk supply. MCN Am J Matern Child Nurs, 1991; 16:312–316.
85.
LauerBJ, SpectorND. Hyperbilirubinemia in the newborn. Pediatr Rev, 2011; 32:341–349.
86.
MaiselsMJ.Screening and early postnatal management strategies to prevent hazardous hyperbilirubinemia in newborns of 35 or more weeks of gestation. Semin Fetal Neonatal Med, 2010; 15:129–135.
87.
SchwartzHP, HabermanBE, RuddyRM. Hyperbilirubinemia: Current guidelines and emerging therapies. Pediatr Emerg Care, 2011; 27:884–889.
88.
WatchkoJF.Identification of neonates at risk for hazardous hyperbilirubinemia: Emerging clinical insights. Pediatr Clin North Am, 2009; 56:671–687.
89.
GulcanH, TikerF, KilicdagH. Effect of feeding type on the efficacy of phototherapy. Indian Pediatr, 2007; 44:32–36.
90.
MaiselsMJ, NewmanTB, WatchkoJ, et al.Phototherapy and other treatments. In: Care of the Jaundiced Neonate, StevensonDK, MaiselsMJ, WatchkoJF, eds. New York: McGraw Hill, 2012, pp. 195–227.
91.
LauSP, FungKP. Serum bilirubin kinetics in intermittent phototherapy of physiological jaundice. Arch Dis Child, 1984; 59:892–894.
92.
VoglTP, HegyiT, HiattIM, et al.Intermediate phototherapy in the treatment of jaundice in the premature infant. J Pediatr, 1978; 92:627–630.
93.
SachdevaM, MurkiS, OletiTP, et al.Intermittent versus continuous phototherapy for the treatment of neonatal non-hemolytic moderate hyperbilirubinemia in infants more than 34 weeks of gestational age: A randomized controlled trial. Eur J Pediatr, 2015; 174:177–181.
94.
de CarvalhoM, HallM, HarveyD. Effects of water supplementation on physiological jaundice in breast-fed babies. Arch Dis Child, 1981; 56:568–569.
95.
NicollA, GinsburgR, TrippJH. Supplementary feeding and jaundice in newborns. Acta Paediatr Scand, 1982; 71:759–761.
96.
HowardCR, HowardFM, LanphearB, et al.Randomized clinical trial of pacifier use and bottle-feeding or cupfeeding and their effect on breastfeeding. Pediatrics, 2003; 111:511–518.
97.
GartnerLM, LeeKS, MoscioniAD. Effect of milk feeding on intestinal bilirubin absorption in the rat. J Pediatr, 1983; 103:464–471.
98.
FlahermanVJ, AbyJ, BurgosAE, et al.Effect of early limited formula on duration and exclusivity of breastfeeding in at-risk infants: An RCT. Pediatrics, 2013; 131:1059–1065.
99.
MartinezJC, MaiselsMJ, OtheguyL, et al.Hyperbilirubinemia in the breast-fed newborn: A controlled trial of four interventions. Pediatrics, 1993; 91:470–473.
100.
UpdegroveKH.Donor human milk banking: Growth, challenges, and the role of HMBANA. Breastfeed Med, 2013; 8:435–437.
KairLR, ColaizyTT, HubbardD, et al.Donor milk in the newborn nursery at the University of Iowa Children's Hospital. Breastfeed Med, 2014; 9:547–550.
103.
BulpittDW, ElmoreKE, CattertonLJ. Implementing use of donor breast milk in the well baby population: It's not just for the NICU any more. J Obstet Gynecol Neonatal Nurs, 2014; 43(Suppl 1):S56.
104.
BrownellEA, LussierMM, HersonVC, et al.Donor human milk bank data collection in North America: An assessment of current status and future needs. J Hum Lact, 2014; 30:47–53.
105.
GourleyGR, LiZ, KreamerBL, et al.A controlled, randomized, double-blind trial of prophylaxis against jaundice among breastfed newborns. Pediatrics, 2005; 116:385–391.
106.
SamraN, El TaweelA, CadwellK. The effect of kangaroo mother care on the duration of phototherapy of infants re-admitted for neonatal jaundice. J Matern Fetal Neonatal Med, 2012; 25:1354–1357.
107.
PaulIM, SchaeferEW, MillerJR, et al.Weight change nomograms for the first month after birth. Pediatrics, 2016; 138:pii: e20162625.
